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The authors previously described srpABC, an operon involved in proton-
dependent solvent efflux in the solvent-tolerant Pseudomonas putida S12.
Recently, it was shown that organic solvents and not antibiotics induce this
operon. In the present study, the authors characterize a new efflux pump,
designated ArpABC, on the basis of two isolated chloramphenicol-sensitive
transposon mutants. The arpABC operon is involved in the active efflux of
multiple antibiotics, such as tetracycline, chloramphenicol, carbenicillin,
streptomycin, erythromycin and novobiocin. The deduced amino acid
sequences encoded by the three genes involved show a striking resemblance
to proteins of the resistance/nodulation/cell division family, which are involved
in both organic solvent and multiple drug efflux. These findings demonstrate
that ArpABC is highly homologous to the MepABC and TtgABC efflux systems
for organic solvents and multiple antibiotics. However, ArpABC does not
contribute to organic solvent tolerance in P. putida S12 but is solely involved in
multidrug resistance.
Keywords : solvent tolerance, multidrug resistance, eﬄux
INTRODUCTION
It is well known that several strains within the family
Pseudomonadaceae show significant intrinsic resistance
to a wide variety of structurally unrelated compounds,
such as antimicrobial agents and organic solvents (for
reviews see Nikaido, 1996; Paulsen et al., 1996; Isken &
de Bont, 1998; Kieboom et al., 2000). In the case of
Pseudomonas aeruginosa it was thought that a very low,
non-specific permeability was the main cause of re-
sistance to antibiotics (Nikaido, 1994). In the case of
Pseudomonas putida several changes at the level of the
membrane contribute to organic solvent tolerance
(Weber & de Bont, 1996; Isken & de Bont 1998).
Nevertheless, the exceptional resistance of Pseudo-
monadaceae cannot be explained solely by the low
permeability of the outer membrane and by changes at
the level of the membrane. Not surprisingly, eﬄux
systems have been identified that contribute to the
exceptional resistance of these strains. These eﬄux
systems, which belong to the resistance}nodulation}cell
division (RND) family of transporters, consist of three
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Abbreviation: RND family, resistance/nodulation/cell division family.
The GenBank accession number for the arp sequence is AF183959.
components : the inner membrane transporter protein
(RND protein), which is attached via a membrane
fusion protein (MFP) to an outer membrane protein
(OMP) (Saier et al., 1994). The OMP is thought to be an
outer membrane channel by which to circumvent the
outer membrane barrier, allowing the pumped molecule
to be released into the medium (Dinh et al., 1994).
In the solvent-tolerant P. putida strain S12 it was shown
that the energy-dependent eﬄux of organic solvents was
the key factor in organic solvent tolerance via the
organic solvent transporter SrpABC (Kieboom et al.,
1998a). Similar eﬄux systems for the active removal of
organic solvents have been found in other P. putida
strains. These RND-type eﬄux systems, encoded by
ttgABC (Ramos et al., 1998), ttgDEF (Mosqueda &
Ramos, 2000) and mepABC (Fukumori et al., 1998), are
involved in the active eﬄux of toxic compounds such as
toluene, p-xylene and styrene. In the case of the
multidrug-resistant P. aeruginosa four eﬄux systems
have been described: MexAB-OprM (Poole et al., 1993),
MexCD-OprJ (Poole et al., 1996), MexEF-OprM
(Kohler et al., 1997) and AmrAB (Westbrock-Wadman
et al., 1999). These systems contribute to the energy-
dependent eﬄux of a wide variety of antimicrobial
agents such as b-lactams, tetracycline, fluoroquinolones
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and chloramphenicol. The interesting question now
arises whether the RND-type transporters are able to
export both antibiotics and solvents. Indications so far
confirm that these pumps have dual pumping capacity.
The mex-encoded eﬄux systems have recently been
shown to be involved in the eﬄux of organic solvent in
P. aeruginosa (Li et al., 1998). Moreover, solvent-
sensitive mutants of P. putida DOT-T1E and P. putida
KT2442 became more sensitive to antibiotics such as
tetracycline, chloramphenicol and ampicillin, suggesting
the active removal of multiple antibiotics by these eﬄux
systems (Ramos et al., 1998; Fukumori et al., 1998).
We have now studied this aspect at the molecular level
and have found a new eﬄux system in P. putida S12 that
is involved in the intrinsic resistance of this strain to a
wide variety of structurally unrelated antibiotics. Se-
quence analysis showed that this eﬄux system is highly
homologous to the solvent}antibiotic transporters
MepABC and TtgABC. Moreover, we demonstrate that
ArpABC in P. putida S12 is only involved in multidrug
resistance and not in tolerance towards organic solvents.
METHODS
Bacterial strains, plasmids and growth of the strains. P.putida
S12 (ATCC 700801) (Hartmans et al., 1989), a wild-type strain
capable of growth at supersaturated solvent concentrations
Table 1. Strains and plasmids used in this study
Strain/plasmid Relevant characteristics* Source or reference
Strains
P. putida S12 Apr Cmr srpABC+ arpABC+ Hartmans et al. (1989)
P. putida JK1 Apr Cmr srpB~TnMod-KmO Kieboom et al. (1998a)
P. putida CM1 Apr Cms arpB~TnMod-KmO This study
P. putida CM2 Apr Cms arpC~TnMod-KmO This study
P. putida DM1 Apr Cms srpB~TnMod-KmO arpA : : tetA-oriR : :arpB This study
E. coli DH5a recA1 Yanisch-Perron et al. (1985)
Plasmids
pTnMod-KmO Kmr, pMB1 replicon Dennis & Zylstra (1998)
pUC18 Apr, cloning vector Life Technologies
pUC19 Apr, cloning vector Life Technologies
pBBR1MCS Cmr, cloning vector, REP replicon Kovach et al. (1994)
pUCP22 Apr Gmr, cloning vector, pRO1600 replicon West et al. (1994)
pKRZ-1 Kmr, promoter probe cloning vector Rothmel et al. (1991)
pACYC184 Tcr, cloning vector Calgene
pJD105 pUCP22 containing srpABC Kieboom et al. (1998a)
pCM1P Kmr arpBC from chromosomal DNA of P. putida CM1 This study
pCM2P Kmr arpBC from chromosomal DNA of P. putida CM2 This study
pCM1B Kmr arpABC from chromosomal DNA of P. putida CM1 This study
pCMPE pUC18 containing arpRA This study
pCMC1 pUCP22 containing arpAB This study
pCMC2 pUCP22 containing arpABC This study
pKRZ-arp pKRZ-1 containing P
arp
lacZ fusion This study
pTO1 Tcr Cms pBBR1MCS containing tetA-oriR This study
pSC1 Tcr arpA : : tetA-oriR : :arpB, pMB1 replicon This study
*Ap, Cm, Km, Gm and Tc represent resistance (r) or sensitivity (s) to ampicillin, chloramphenicol, kanamycin, gentamicin and
tetracycline, respectively.
(Weber et al., 1993), was the object of the present investigation.
Mutant strains of P. putida S12 generated in this study and
those generated previously are shown in Table 1. Escherichia
coli DH5a (Yanisch-Perron et al., 1985) was utilized as host
strain for all recombinant plasmids. The cloning vectors used
and the plasmids generated in this study are shown in Table 1.
Luria–Bertani (LB) broth (Sambrook et al., 1989) was used as
complete medium. For electroporation, cells were grown in
10 g tryptone l−" and 5 g yeast-extract l−". Solid media
contained 2% agar. Ampicillin (100 lg ml−"), kanamycin
(50 lg ml−"), gentamicin (10 lg ml−") and tetracycline
(50 lg ml−") were added to the medium to maintain recom-
binant plasmids in E. coli and P. putida. The E. coli strains
were routinely cultured at 37 °C and P. putida strains were
grown at 30 °C.
Generation and screening of TnMod-KmO insertion mutants.
The plasposon TnMod-KmO was introduced into P. putida
S12 by electroporation (Dennis & Sokol, 1995). Kanamycin-
resistant transposon mutants were tested for their ability to
grow on LB agar plates supplemented with 100 lg chloram-
phenicol ml−" and 50 lg kanamycin ml−". Mutants were
incubated at 30 °C for 24 h. Mutants unable to grow in the
presence of 100 lg chloramphenicol ml−" were selected.
DNA techniques. Total genomic DNA from P. putida strains
was prepared by the CTAB procedure (Ausubel et al., 1991).
Plasmid DNA was isolated by the alkaline SDS lysis method of
Birnboim & Doly (1979). DNA was digested with restriction
enzymes and ligated with T4 ligase as recommended by the
supplier (Life Technologies). DNA restriction fragment and
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PCR products were visualized by 0–8% agarose gel electro-
phoresis in 45 mM Tris}borate, 1 mM EDTA buffer. DNA
from agarose gels was isolated using the method of Vogelstein
& Gillespie (1979). Southern analyses of chromosomal DNA
and colony hybridizations were carried out according to
Maniatis et al. (1982). Probes were labelled with DIG-dUTP
using the PCR DIG Probe Synthesis Kit (Boehringer
Mannheim) with the appropriate primers. Southern blot
hybridizations were carried out by chemiluminescent de-
tection under high-stringency conditions as described by the
supplier (Boehringer Mannheim). Plasmid DNA was intro-
duced into either E. coli DH5a or P. putida cells by
electroporation (Dennis & Sokol, 1995) using a Gene Pulser
(Bio-Rad).
DNA sequences of both strands of the arpABC operon were
determined by a combination of subcloning and primer
walking. All sequencing and PCR reactions were performed
using a Gene Amp PCR System 9700 (Perkin-Elmer). Nucleo-
tide sequencing reactions were performed with purified
double-strand plasmid DNA using AmpliTaq FS DNA poly-
merase fluorescent dye terminator reactions (Perkin-Elmer) as
recommended by the supplier. Sequencing products were
detected using an Applied Biosystems 373A stretch automated
DNA sequencer. Nucleotide sequence analysis was performed
either with the Lasergene analysis package (DNASTAR) or
with the National Centre for Biotechnology Information
blast server (Altschul et al., 1990).
Construction of pCMC2 for complementation. For the com-
plementation experiments we reconstructed the arpABC
operon since the clones obtained from P. putida CM1 and
CM2 contain the transposon-mutagenized DNA. Therefore, a
2–2 kb BamHI–PstI fragment from pCM1B was cloned into the
broad-host-range vector pUCP22; the resulting plasmid was
designated pCMC1. A 2–3 kb PstI–EcoRI fragment from
pCM2P and a 2–0 kb EcoRI–PstI fragment from pCM1P were
ligated into PstI-digested and alkaline-dephosphatase-treated
pCMC1. The resulting plasmid, pCMC2, contained the
arpABC genes in the same orientation as the lac promoter and
was transferred to the mutant strains CM1 and CM2.
Construction of suicide plasmid pSC1. We amplified a 1289 bp
fragment containing the tetracycline-resistance gene tetA from
pACYC184. The primers 5«-CGGAATTCTCATGTTTGA-
CAGCT-3« and 5«-GCGGTACCTCAGGTCGAGGTGG-3«
contain added recognition sites for EcoRI and KpnI, re-
spectively. The reaction mixture (50 ll) was treated for
10 min at 94 °C followed by 35 cycles of 1 min at 94 °C, 2 min
at 55 °C and 1 min at 72 °C before finishing for 10 min at
72 °C. This 1–3 kb EcoRI–KpnI fragment and a 0–7 kb KpnI–
SstI fragment from TnMod-KmO, containing theColE1 origin
of replication, were ligated in EcoRI- and SstI-digested
pBBR1MCS, resulting in pTO1. The suicide plasmid pSC1
was constructed by ligating a 2–0 kb EcoRI–SstI fragment from
pTO1, a 3–0 kb PstI–SstI fragment from pCM1P and a 3–0 kb
PstI–EcoRI fragment from pCMPE.
Construction of pKRZ-arp and determination of b-galacto-
sidase activity. PCR reactions for amplifying the region of
genomic P. putida S12 DNA containing the arp promoter were
performed using Super Taq DNA polymerase (SphearoQ).
The reaction mixture (50 ll) was treated for 10 min at 94 °C
followed by 35 cycles of 1 min at 94 °C, 1 min at 58 °C and
1 min at 72 °C before finishing for 10 min at 72 °C. Primers for
this reaction were 5«-CCGCTCGAGTACAACCTCATCTG-
GCCC-3« and 5«-CGCTCTAGAATTGCATGAGGATCCT-
CG-3«, which amplified a 276 bp fragment corresponding to
the region immediately upstream of the arpABC genes. The
primers contain added recognition sites for XhoI and XbaI,
respectively. b-Galactosidase activity in P. putida S12(pKRZ-
arp) was determined by growing the cells to late-exponential
phase at 30 °C in 10 ml LB broth supplemented with inducer.
The b-galactosidase activity in these experiments was de-
termined in triplicate by the method of Miller (1972) using
chloroform and SDS to permeabilize the cells.
Determination of solvent tolerance and the MIC of anti-
biotics. Solvent tolerance of the P. putida strains was
determined in duplicate by growing the cells in 10 ml liquid LB
medium in 100 ml flasks supplemented with 1 mM magnesium
chloride. Toluene and p-xylene (1% final concentration) were
separately added to identical subcultures in LB}MgCl
#
me-
dium during the early exponential growth phase. The maximal
aqueous benzene concentration was determined by adding
increasing amounts of benzene. Growth of the cultures was
measured 24 h after solvent addition with no continued
growth indicating solvent sensitivity. The MIC for various
antibiotics was determined in duplicate by threefold serial
dilution in LB broth in microtitre plates. The inoculum was
1% of an overnight culture and growth was determined by
measuring the OD
’!!
after 36 h at 30 °C.
RESULTS
Isolation of chloramphenicol-sensitive mutants
P. putida S12 is able to grow in the presence of a wide
variety of normally toxic solvents and is relatively
resistant to various antibiotics. Chloramphenicol-sen-
sitive mutants were obtained by electroporating the
transposon TnMod-KmO into P. putida S12. Over 4000
kanamycin-resistant transposon mutants were con-
structed, with an overall transformation efficiency for
TnMod-KmO of 1–5‹10$ per lg DNA. These mutants
were tested for growth on solid LB medium supple-
mented with 100 lg chloramphenicol ml−". Two
chloramphenicol-sensitive mutants were isolated and
were designated strains CM1 and CM2, respectively.
.................................................................................................................................................
Fig. 1. Restriction maps of the clones derived from the
transposon mutants CM1 and CM2. A diagram of the arp
nucleotide sequence is shown at the bottom, in proportion to
the restriction maps and showing the positions of the genes
relative to the restriction enzyme cutting sites. The triangles in
the restriction maps indicate the location of the inserted
plasposon TnMod-KmO in the cloned genomic DNA.
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Fig. 2. Nucleotide sequence of the relevant portions of a 7313 bp fragment containing the arp genes. The deduced
amino acid sequences of the encoded proteins are shown beneath the nucleotide sequence. Termination codons are
indicated with an asterisk and putative ribosome-binding sites and a putative r70-dependent promoter motif that
resembles the E. coli consensus motif 5’-TTGACA-N(15–19)-TATAAT-3’ have been marked with boxes. Inverted repeat
sequences are indicated in black boxes. An arrow indicates the position of TnMod-KmO in P. putida CM1 and P. putida
CM2 (position 3594 and 5738 of the arpABC sequence, respectively). The GenBank accession number for the arp sequence
is AF183959.
Cloning and analysis of the genes for
chloramphenicol resistance
To characterize the genes for chloramphenicol resistance
in P. putida S12, the regions of the genome containing
the transposon insertion in mutants CM1 and CM2
(both 5–8 kb) were cloned. From both mutants a clone
was obtained from PstI-digested chromosomal DNA;
the clones were designated pCM1P and pCM2P, re-
spectively. Genomic DNA cut with BamHI from strain
CM1 was used to construct the 14–0 kb plasmid pCM1B.
Plasmid pCM1B was shown to contain a complete
operon, including the inserted TnMod-KmO (Fig. 1).
The nucleotide sequence of the operon was determined
and screening for similar nucleotide sequences in the
GenBank database revealed a significant match with
genes encoding multidrug and solvent export pumps.
We labelled the genes arp, for antibiotic resistance
pump. A diagram of the nucleotide sequence obtained is
presented in Fig. 1 to show the relationship of the open
reading frames with the three clones pCM1P, pCM2P
and pCM1B. The deduced nucleotide sequences of arpA,
arpB and arpC encode proteins of 371, 1050 and 484
amino acid residues with calculated molecular masses
of 40–3, 112–8 and 52–8 kDa, respectively. Putative
ribosome-binding sites precede the arpABC genes and a
stable stem-loop structure was found downstream of
arpC that may function as transcriptional terminator
(Fig. 2).
Construction of an arpABC mutant of P. putida JK1
The presence of the solvent eﬄux pump SrpABC in P.
putida CM1 and CM2 could mask the possible eﬄux of
organic solvent by ArpABC. Therefore, to determine the
role of ArpABC in solvent tolerance we decided to
inactivate the arpABC gene cluster by site-specific
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Table 2. Determination of the MIC of various antibiotics for the P. putida strains
.....................................................................................................................................................................................................................................
The MIC for antibiotics was determined in duplicate by threefold serial dilution in LB broth in
microtitre plates. The inoculum was 1% of an overnight culture and growth was determined by
measuring the OD
’!!
after 36 h at 30 °C. nd, Not determined.
Antibiotic MIC (lg ml−1) for strain :
S12 CM1 CM2 CM1(pCMC2) CM2(pCMC2)
Tetracycline 16 1 2 16 16
Chloramphenicol 64 16 16 128 128
Ampicillin 256 64 128 nd nd
Carbenicillin 1024 4 4 nd nd
Streptomycin 32 8 8 64 64
Erythromycin 128 8 4 128 256
Rifampicin 64 32 32 32 32
Polymyxim B 16 8 8 8 8
Nalidixic acid 256 128 128 256 256
Novobiocin 1024 64 128 1024 1024
Penicillin G " 4094 2048 4094 nd nd
reciprocal recombination in the solvent-sensitive trans-
poson mutant P. putida JK1, creating a srp-arp double
mutant. We electroporated P. putida JK1 with the
suicide plasmid pSC1 (Table 1) replacing part of arpA
and arpB with the ColE1 origin of replication and
tetracycline resistance gene, resulting in the srp-arp
double mutant P. putida DM1. Recombination was
confirmed by hybridization of P. putida DM1 chromo-
somal DNA with a probe for the tetA gene (data not
shown).
Complementation of P. putida mutants
Complementation experiments were performed to prove
that the TnMod-KmO-inserted open reading frames
detected in P. putida CM1 and CM2 are actually
responsible for chloramphenicol resistance. These
complemented strains regained chloramphenicol resist-
ance similar to the wild-type levels (Table 2). These
results are consistent with the chloramphenicol-resist-
ance phenotype being dependent on expression of the
arpABC genes. We tested a variety of structurally
unrelated antibiotics, which are known substrates for
homologous eﬄux systems of the RND family of
transporters (Nikaido, 1996; Paulsen et al., 1996).
Mutants CM1 and CM2 were not only sensitive to
chloramphenicol but also to a number of other anti-
biotics (Table 2), demonstrating that a single genetic
trait in P. putida S12 is responsible for resistance to the
antibiotics tested.
Solvent resistance of the P. putida strains
P. putida S12 is resistant to organic solvents mainly
through the presence of a solvent eﬄux system (Isken &
de Bont, 1996; Kieboom et al., 1998a). Therefore, it was
Table 3. Solvent tolerance of the P. putida strains
.................................................................................................................................................
Solvent tolerance of the P. putida strains was determined in LB
broth supplemented with 1 mM magnesium chloride. A plus
indicates growth with 1% organic solvent after 24 h at 30 °C.
Solvent Strain:
S12 CM1 CM2 JK1 DM1
Benzene 10 mM 10 mM 10 mM 6 mM 6 mM
Toluene › › › fi fi
p-Xylene › › › fi fi
determined whether the ArpABC eﬄux pump was
involved in solvent resistance in P. putida S12. The
antibiotic-sensitive mutant strains CM1 and CM2 were
as resistant as the wild-type strain to benzene, toluene
and p-xylene, whereas the srp-arp double mutant DM1
was as sensitive to organic solvents as the solvent-
sensitive JK1 strain (Table 3). These results indicate that
the solvent-resistance phenotype of P. putida S12 is not
dependent on expression of arpABC genes.
Cloning and induction of the arpABC promoter
To clone and sequence the promoter region and possible
regulatory genes of the arp operon, we examined the
region upstream of the BamHI site of pCM1B. There-
fore, we isolated approximately 3–0 kb P. putida S12
chromosomal DNA fragments digested with PstI and
EcoRI. These fragments were cloned into pUC18 cut
with PstI and EcoRI. We were able to isolate the plasmid
from one colony out of 1200 by colony hybridization
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Table 4. Amino acid sequence identity between ArpABC and multidrug and solvent efflux proteins
Organisms Eﬄux system proteins* :
MFP Identity (%) RND Identity (%) OMP Identity (%) RP Identity (%)
P. putida ArpA 100 ArpB 100 ArpC 100 ArpR 100
TtgA 99–7 TtgB 99–9 TtgC 99–6 – –
MepA 99–2 MepB 99–9 MepC 99–8 MepR 98–6
TtgD 58–0 TtgE 62–2 TtgF 56–6 – –
SrpA 57–1 SrpB 63–4 SrpC 57–3 SrpR 30–9
SrpS 27–3
P. aeruginosa MexA 67–6 MexB 78–1 OprM 69–4 MexR 37–5
AmrA 37–4 AmrB 48–7 – – AmrR 32–2
MexC 43–1 MexD 48–4 OprJ 41–6 – –
MexE 29–6 MexF 41–4 OprN 28–4 MexT 22–0
E. coli AcrA 53–8 AcrB 65–4 TolC 19–3 AcrR 37–6
AcrE 50–6 AcrF 64–4 – – EnvR 30–3
N. gonorrhoeae MtrC 43–3 MtrD 46–6 MtrE 39–7 MtrR 33–0
*MFP, membrane fusion protein; RND, eﬄux protein; OMP, outer membrane protein; RP, regulatory protein. Identity (matches over
matches, mismatches and gaps) was calculated with the Lipman–Pearson algorithm using the deduced amino acid sequences of ArpA,
ArpB, ArpC and ArpR (GenBank accession no. AF183959); TtgA, TtgB and TtgC (AF031417); MepA, MepB, MepC and MepR
(AB008909); TtgD, TtgE and TtgF (PPY19106); SrpA, SrpB and SrpC (AF029405) : SrpR and SrpS (AF061937); MexA and MexB (L11616);
OprM (L23839); MexR (U23763); AmrA, AmrB and AmrR (AF147719); MexC, MexD and OprJ (U57969); MexE, MexF and OprN
(X99514); MexT (AJ007825); AcrA and AcrB (U00734); TolC (X00016); AcrR (U00734); AcrE and AcrF (AE000405); EnvR (X57648);
MtrC (U14993); MtrD (U60099); MtrC (X95635) and MtrR (Z25797).
with a 0–7 kb BamHI–EcoRI fragment from pCM1B.
This plasmid, pCMPE, contained the complete pro-
moter region and an ORF (arpR) that was transcribed in
the opposite direction to that of arpABC (Fig. 1). The
arpR gene product (ArpR) was most similar to MepR
(98–6% amino acid identity), which is a putative
regulator of the MepABC organic solvent transporter
(Fukumori et al., 1998) (Table 4). The deduced sequence
of arpR encodes a protein of 210 amino acid residues
with a calculated molecular mass of 23–8 kDa. Sequence
analysis of the ArpR revealed a TetR family signature
motif. A putative ribosome-binding site preceded the
arpR gene and a stable stem–loop structure was found
downstream of arpR and may function as tran-
scriptional terminator (Fig. 2). Moreover, a putative
r(!-dependent promoter consensus motif was found
upstream of the start of arpA.
The P. putida S12 solvent transporter is solely induced
by organic solvents (Kieboom et al., 1998b). In this light
it was interesting to examine the induction of the
multidrug transporter ArpABC. Therefore, the putative
promoter region of the arpABC operon was amplified by
PCR and cloned in the lacZ reporter plasmid pKRZ-1
(Rothmel et al., 1991) cut with XbaI and SalI. The
resulting plasmid, designated pKRZ-arp, was electro-
porated into P. putida S12. P. putida S12(pKRZ-arp)
was grown in LB broth in the absence and presence of
the antibiotics chloramphenicol, carbenicillin and
erythromycin and the solvents toluene, p-xylene and
hexane. b-Galactosidase activity was subsequently
assayed in late exponential phase (OD
’!!
1–0). No
significant induction was observed by any of these
compounds.
DISCUSSION
In this report we describe the isolation and charac-
terization of chloramphenicol-sensitive mutants from
the solvent-tolerant and multidrug-resistant bacterium
P. putida S12. Two chloramphenicol-sensitive mutants
were isolated and sequence analysis showed that both
mutants were disrupted in the same operon. Multidrug
eﬄux systems play an important role in the intrinsic
resistance of members of the family of Pseudo-
monadaceae to a variety of antibiotics. At present four
antibiotic eﬄux systems have been described in P.
aeruginosa :MexAB-OprM (Poole et al., 1993),MexCD-
OprJ (Poole et al., 1996), MexEF-OprM (Kohler et al.,
1997) and AmrAB (Westbrock-Wadman et al., 1999).
These systems are involved in the proton-dependent
eﬄux of antimicrobial agents such as b-lactams, tetra-
cyclines, fluoroquinolones and chloramphenicol. In
P. putida TtgABC (Ramos et al., 1998), MepABC
(Fukumori et al., 1998) and the ArpABC eﬄux system
described in this report are involved in tolerance towards
antibiotics such as tetracycline, chloramphenicol,
carbenicillin, streptomycin, erythromycin and novo-
biocin. Our findings demonstrate that the ArpABC
eﬄux system is a key mechanism in multidrug resistance
in P. putida S12.
Proton-dependent eﬄux systems also play an important
role in organic solvent tolerance in P. putida strains
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(Kieboom et al., 1998a; Ramos et al., 1998; Fukumori et
al., 1998). The first RND-type eﬄux system for toluene
was isolated by Kieboom et al. (1998) and was shown to
be responsible for organic solvent tolerance in P. putida
S12 (Kieboom et al., 1998a). The involvement of eﬄux
systems in solvent tolerance was confirmed with the
isolation of the ttgABC, ttgDEF genes from P. putida
DOT-T1E (Ramos et al., 1998; Mosqueda & Ramos,
2000) and the mepABC genes from P. putida KT2442
(Fukumori et al., 1998). Moreover, Kim et al. (1998)
reported that a transposon insertion in a protein of the
RND family resulted in a P. putida mutant with a
solvent-sensitive phenotype. Surprisingly, other studies
suggested that the isolated solvent transporter in
P. putida was also involved in the active eﬄux of
multiple antibiotics (Ramos et al., 1998; Fukumori
et al., 1998). A toluene-sensitive mepB~Tn5 mutant of a
P. putida KT2442 was also sensitive to ampicillin,
penicillin G, erythromycin, novobiocin and tetracycline
(Fukumori et al., 1998); and a toluene-sensitive ttgB~
mini-Tn5«phoA-Kmr mutant of P. putida DOT-T1E
was sensitive to chloramphenicol, ampicillin and tetra-
cycline (Ramos et al., 1998). With the construction of a
srp-arp double mutant we were able to demonstrate that
the ArpABC eﬄux system was not involved in organic
solvent tolerance in P. putida S12.
An interesting, but as yet not completely clear, picture is
now emerging from studies on the eﬄux pumps of
pseudomonads with regard to both their substrate
recognition and their induction patterns. The inherent
problem in studying these aspects is that responses to
doses of antibiotics or organic solvents must be
monitored at the whole-cell level. Both wild-type cells
and mutants may or may not contain additional, and
often unknown, pumps. Moreover, the rate of influx of
compounds will depend on their chemical structure,
while the cell may alter the composition of its cell
envelope, thus further obscuring the explanation of
results. Nevertheless, on the basis of this type of
experimentation it is now possible to distinguish three
types of proton-dependent eﬄux systems in pseudo-
monads on the basis of compounds expelled from the
cell. To date two eﬄux pumps have been described that
are solely involved in the eﬄux of solvents and do not
appear to be able to export antibiotics. This type of
eﬄux pump includes SrpABC in P. putida S12 and
TtgDEF in P. putida DOT-T1E and was shown to be
induced by organic solvents (Kieboom et al., 1998a;
Mosqueda & Ramos, 2000). Most of the eﬄux systems
characterized in pseudomonads, however, export both
antibiotics and solvents. These systems include the
constitutive TtgABC pump in P. putida DOT-T1E
(Ramos et al., 1998), the MepABC pump in P. putida
KT2442 (Fukumori et al., 1998) and the Mex eﬄux
systems in P. aeruginosa (Li et al., 1998). The third type
is the ArpABC system reported here, which is involved
in antibiotic resistance but not in solvent tolerance as
shown by the phenotype of the srp-arp double mutant.
However, a note of caution in identifying ArpABC as an
antibiotic-removing pump and not as a solvent-remov-
ing system is appropriate. A solvent pump has to operate
at a higher speed than an antibiotic pump due to the
considerably higher influx of hydrophobic solvents
compared to the influx of antibiotics. Toluene may be
present at 5 mM in the aqueous phase, while antibiotics
usually remain below 1 mM and it is to be expected that
antibiotics will diffuse more slowly into the cell than do
uncharged, small solvent molecules. Consequently, sol-
vent eﬄux pumps may have to generate an eﬄux that is
probably 10–100 times higher than the eﬄux created by
the antibiotic pumps. If the expression level is not
affected by the presence of solvent as substrate, as is the
case for the ArpABC system, then the solvent-pumping
ability may not be registered at the whole-cell level. We
have tried to overcome this pitfall by using benzene as
test solvent and by employing it at different concen-
trations. This method should be relatively suitable for
detecting minor contributions to solvent pumping, but
nevertheless, no effect of the presence of ArpABC on
benzene sensitivity was observed.
The grouping of the known Pseudomonas eﬄux pumps
according to their pumping activity for either solvent
and}or antibiotics is not supported by the molecular
structure of these pumps. The ArpB, TtgB and MepB
proteins are almost identical at the amino acid level,
which is quite surprising because they have been
identified in strains isolated from three very different
locations. Also, their A and C components are almost
identical. ArpB differs only in one amino acid from TtgB
(Ala-544 to Gly-544), while compared to MepB it differs
in three amino acids (Ala-533 to Thr-533, Ala-544 to
Gly-544 and Glu-692 to Ala-692). On the basis of the
MexB membrane topology (Guan et al., 1999) it is
expected that Ala-544 is located in a putative trans-
membrane segment, whereas Ala-544 and Glu-692 are
periplasmic. These observations would lead to the
conclusion that Gly-544 might be a key amino acid in
interactions with antibiotics. However, as yet the
substrate-binding domain of RND-type proteins has not
been identified.
Alternatively, it might be argued that MepABC and
TtgABC are present at higher levels in their respective
hosts. For P. putida KT2442 it was anticipated that the
mep operon was overexpressed in the toluene-tolerant
variant TOL. Possibly a similar adaptation phenomenon
has taken place already during the isolation of strain P.
putida DOT-T1E. Therefore, in both strains, a high
transcription level of the eﬄux operons may result in a
high solvent eﬄux, required for the cell to survive in the
presence of toluene. Similar results were reported for the
mexAB-oprM eﬄux system in P. aeruginosa. In this
strain a single substitution in the mexR regulator
resulted in the overexpression of MexAB-OprM
resulting in an increased multidrug resistance and
organic solvent tolerance (Poole et al., 1996; Li et al.,
1998; Li & Poole, 1999).
In summary, the intrinsic resistance of P. putida S12 to
multiple antibiotics is due to eﬄux of these components
by ArpABC. Whether ArpABC in P. putida S12 is unable
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to transport solvent due to an amino acid substitution or
due to the lack of overexpression, the extrusion of
organic solvents by this eﬄux system is too low to
prevent their influx but sufficiently high to combat the
antibiotic influx. P. putida S12 does not have to rely on
ArpABC-mediated solvent eﬄux for its solvent-tolerant
phenotype, since it possesses the SrpABC eﬄux system
that is induced under solvent stress.
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J.
(1990). Basic local alignment search tool. J Mol Biol 215, 403–410.
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman,
J. G., Smith, J. A. & Struhl, K. (editors) (1991). Current Protocols
in Molecular Biology. New York: Greene Publishing Associates.
Birnboim, H. C. & Doly, J. (1979). A rapid alkaline extraction
procedure for screening recombinant plasmid DNA. Nucleic
Acids Res 7, 1513–1523.
Dennis, J. J. & Sokol, P. A. (1995). Electrotransformation of
Pseudomonas. Methods Mol Biol 47, 125–133.
Dennis, J. J. & Zylstra, G. J. (1998). Plasposons: modular self-
cloning minitransposon derivatives for rapid genetic analysis of
Gram-negative bacterial genomes. Appl Environ Microbiol 64,
2710–2715.
Dinh, T., Paulsen, I. T. & Saier, M. H., Jr (1994). A family of
extracytoplasmic proteins that allow transport of large molecules
across the outer membranes of gram-negative bacteria. J Bacteriol
176, 3825–3831.
Fukumori, F., Hirayama, H., Takami, H., Inoue, A. & Horikoshi, K.
(1998). Isolation and transposon mutagenesis of a Pseudomonas
putida KT2442 toluene-resistant variant : involvement of an eﬄux
system in solvent tolerance. Extremophiles 2, 395–400.
Guan, L., Ehrmann, M., Yoneyma, H. & Nakae, T. (1999).
Membrane topology of the xenobiotic-exporting subunit, MexB,
of the MexAB-OprM extrusion pump in Pseudomonas aeru-
ginosa. J Biol Chem 274, 10517–10522.
Hartmans, S., Smits, J. P., van der Werf, M., Volkering, J. F. & de
Bont, J. A. M. (1989). Metabolism of styrene oxide and 2-
phenylethanol in the styrene degrading Xanthobacter strain 124X.
Appl Environ Microbiol 55, 2850–2855.
Isken, S. & de Bont, J. A. M. (1996). Active eﬄux of toluene in a
solvent-resistant bacterium. J Bacteriol 178, 6056–6058.
Isken, S. & de Bont, J. A. M. (1998). Bacteria tolerant to organic
solvents. Extremophiles 2, 229–238.
Kieboom, J. & de Bont, J. A. M. (2000). Mechanisms of organic
solvent resistance in bacteria. In Bacterial Stress Responses, pp.
393–402. Edited by G. Storz & R. Hengge-Aronis. Washington,
DC: American Society for Microbiology.
Kieboom, J., Dennis, J. J., de Bont, J. A. M. & Zylstra, G. J. (1998a).
Identification and molecular characterization of an eﬄux pump
involved in Pseudomonas putida S12 solvent tolerance. J Biol
Chem 273, 85–91.
Kieboom, J., Dennis, J. J., Zylstra, G. J. & de Bont, J. A. M.
(1998b). Active eﬄux of organic solvents in Pseudomonas putida
S12 is induced by solvents. J Bacteriol 180, 6769–6772.
Kim, K., Lee, L., Lee, K. & Lim, D. (1998). Isolation and
characterization of toluene-sensitive mutants from the toluene-
resistant bacterium Pseudomonas putida GM73. J Bacteriol 180,
3692–3696.
Kohler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty,
L. K. & Pechere, J.-C. (1997). Characterization of the MexE-MexF-
OprN, a positively regulated multidrug eﬄux system of Pseudo-
monas aeruginosa. Mol Microbiol 23, 345–354.
Kovach, M. E., Phillips, R. W., Elzer, P. H., Roop, R. M., II &
Peterson, K. M. (1994). pBBR1MCS: a broad-host-range cloning
vector. Biotechniques 16, 801–802.
Li, X.-Z. & Poole, K. (1999). Organic solvent-tolerant mutants of
Pseudomonas aeruginosa display multiple antibiotic resistance.
Can J Microbiol 45, 18–22.
Li, X.-Z., Zhang, L. & Poole, K. (1998). Role of the multidrug eﬄux
systems of Pseudomonas aeruginosa in organic solvent tolerance.
J Bacteriol 180, 2987–2991.
Maniatis, T. E., Fritsch, E. F. & Sambrook, J. (1982). Molecular
Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold
Spring Harbor Laboratory.
Miller, J. (1972). Experiments in Molecular Biology. Cold Spring
Harbor, NY: Cold Spring Harbor Laboratory.
Mosqueda, G. & Ramos, J. L. (2000). A set of genes encoding a
second toluene eﬄux system in Pseudomonas putida DOT-T1E is
linked to the tod genes for toluene metabolism. J Bacteriol 182,
937–43.
Nikaido, H. (1994). Prevention of drug access to bacterial targets :
role of permeability barriers and active eﬄux. Science 264,
382–388.
Nikaido, H. (1996). Multidrug eﬄux pumps of Gram-negative
bacteria. J Bacteriol 178, 5853–5859.
Paulsen, I. T., Brown, M. H. & Skurray, R. A. (1996). Proton-
dependent multidrug eﬄux systems. Microbiol Rev 60, 575–608.
Poole, K., Krebes, K., McNally, C. & Neshat, S. (1993). Multiple
antibiotic resistance in Pseudomonas aeruginosa : evidence for
involvement of an eﬄux operon. J Bacteriol 175, 7363–7372.
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E. & Bianco,
N. (1996). Expression of the multidrug resistance operon mexA-
mexB-oprM in Pseudomonas aeruginosa : mexR encodes a
regulator of operon expression. Antimicrob Agents Chemother
40, 2021–2028.
Ramos, J. L., Duque, E., Godoy, P. & Segura, A. (1998). Eﬄux
pumps involved in toluene tolerance in Pseudomonas putida
DOT-T1E. J Bacteriol 180, 3323–3329.
Rothmel, R. K., Shinabarger, D. L., Parsek, M. R., Aldrich, T. L. &
Chakrabarty, A. M. (1991). Functional analysis of the Pseudo-
monas putida regulatory protein CatR: transcriptional studies
and determination of the CatR DNA-binding site by hydroxyl-
radical footprinting. J Bacteriol 173, 4717–4724.
Saier, M. H., Jr, Tam, R., Reizer, A. & Reizer, J. (1994). Two novel
families of bacterial membrane proteins concerned with nodu-
lation, cell division and transport. Mol Microbiol 11, 841–847.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular
Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor,
NY: Cold Spring Harbor Laboratory.
Vogelstein, B. & Gillespie, D. (1979). Preparative and analytical
purification of DNA from agarose. Proc Natl Acad Sci U SA 76,
615–619.
Weber, F. J. & de Bont, J. A. M. (1996). Adaptation mechanisms of
microorganisms to the toxic effects of organic solvents on
membranes. Biochim Biophys Acta 1286, 225–245.
Weber, F. J., Ooijkaas, L. P., Schemen, R. M. W., Hartmans, S. &
de Bont, J. A. M. (1993). Adaptation of Pseudomonas putida S12
to high concentrations of styrene and other organic solvents. Appl
Environ Microbiol 59, 3502–3504.
West, S. E., Schweizer, H. P., Dall, C., Sample, A. K. & Runyen-
Janecky, L. J. (1994). Construction of improved Escherichia–
50
P. putida S12 multidrug eﬄux system
Pseudomonas shuttle vectors derived from pUC18}19 and se-
quence of the region required for their replication in Pseudomonas
aeruginosa. Gene 148, 81–86.
Westbrock-Wadman, S., Sherman, D. R., Hickey & 7 other authors
(1999). Characterization of a Pseudomonas aeruginosa eﬄux
pump contributing to aminoglycoside impermeability. Anti-
microb Agents Chemother 43, 2975–83.
Yanisch-Perron, C., Vieira, J. & Messing, J. (1985). Improved M13
phage cloning vectors and host strains : nucleotide sequences of
the M13mp18 and pUC19 vectors. Gene 33, 103–119.
.................................................................................................................................................
Received 17 May 2000; revised 25 August 2000; accepted 19 September
2000.
51
